Â¥
15.52
Nov 8
New Key Statistics Module, Z-Score and F-Score
SZSE:300142 Key Ratios
Market Cap ¥ M | 24,821.89 |
Enterprise Value ¥ M | 22,100.11 |
P/E(ttm) | 201.56 |
PE Ratio without NRI | 50.55 |
Forward PE Ratio | 34.47 |
Price/Book | 2.59 |
Price/Sales | 8.00 |
Price/Free Cash Flow | 152.14 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.03 |
Revenue (TTM) ¥ M | 3,097.00 |
EPS (TTM) ¥ | 0.08 |
Beneish M-Score | -2.7 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 4.00 |
y-y EBITDA Growth Rate % | -79.90 |
EV-to-EBIT | 107.14 |
EV-to-EBITDA | 107.14 |
PEG | 12.64 |
Shares Outstanding M | 1,599.35 |
Net Margin (%) | 3.95 |
Operating Margin % | 17.99 |
Pre-tax Margin (%) | 6.41 |
Quick Ratio | 2.72 |
Current Ratio | 3.10 |
ROA % (ttm) | 0.80 |
ROE % (ttm) | 1.29 |
ROIC % (ttm) | 4.84 |
Dividend Yield % | 0.06 |
Altman Z-Score | 5.11 |
SZSE:300142 Number of Guru Trades
SZSE:300142 Volume of Guru Trades
Gurus Latest Trades with SZSE:300142
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300142 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Walvax Biotechnology Co Ltd Insider Transactions
No Available Data